Shijiazhuang Yiling Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Shijiazhuang Yiling Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Shijiazhuang Yiling Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Shijiazhuang Yiling Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Shijiazhuang Yiling Pharmaceutical Catalyst Calendar
Proactively evaluate Shijiazhuang Yiling Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Shijiazhuang Yiling Pharmaceutical Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Dec 2020 | Phase I Trial Completion | Hangzhou Tigermed Consulting Co Ltd; Shijiazhuang Yiling Pharmaceutical Co Ltd | 002603; 300347 | XY-0206 | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Advanced Malignancy; Carcinomas; Gastrointestinal Stromal Tumor (GIST); Kidney Cancer (Renal Cell Cancer); Metastatic Cancer; Non-Small Cell Lung Cancer; Pancreatic Cancer; Solid Tumor | Clinical Trial Registry |
| 01 Aug 2020 | Phase I Trial Initiation | Proswell Medical Co; Shijiazhuang Yiling Pharmaceutical Co Ltd | 002603 | XY-0206 | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Clinical Trial Registry |
| 01 Apr 2020 | Phase II Trial Completion | Shijiazhuang Yiling Pharmaceutical Co Ltd | 002603 | felbinac trometamol | Central Nervous System; Genito Urinary System And Sex Hormones; Musculoskeletal Disorders; Oncology; Other Diseases | Back Pain; Gouty Arthritis (Gout); Neuropathic Pain (Neuralgia); Pain; Post-Operative Pain; Renal Stones/Calculi; Trauma; Unspecified Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer